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Multilocus sequence typing (MLST) is an important tool for the global surveillance of bacterial pathogens
that is performed by comparing the sequences of designated housekeeping genes. We developed and tested a
novel mass spectrometry-based method for MLST of Streptococcus pneumoniae. PCR amplicons were subjected
to in vitro transcription and base-specific cleavage, followed by analysis of the resultant fragments by using
matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS). Comparison
of the cleavage fragment peak patterns to a reference sequence set permitted automated identification of
alleles. Validation experiments using 29 isolates of S. pneumoniae revealed that the results of MALDI-TOF MS
MLST matched those obtained by traditional sequence-based MLST for 99% of alleles and that the MALDI-
TOF MS method accurately identified two single-nucleotide variations. The MADLI-TOF MS method was then
used for MLST analysis of 43 S. pneumoniae isolates from Papua New Guinean children. The majority of the
isolates present in this population were not clonal and contained seven new alleles and 30 previously unre-
ported sequence types.
Streptococcus pneumoniae is an important human pathogen
that causes respiratory tract infections, bacteremia, and men-
ingitis (17). Worldwide, it is the most common cause of pneu-
monia and a leading killer of children under the age of 5 years,
especially in developing countries (16, 20, 26). S. pneumoniae
frequently colonizes the nasopharynx of healthy children. Al-
though nasopharyngeal carriage is generally asymptomatic, it is
a prerequisite for disease and serves as a reservoir for S. pneu-
moniae in human populations. S. pneumoniae is a diverse spe-
cies, with over 90 immunologically distinct serotypes. The
changing prevalences in serotype carriage following vaccina-
tion (1, 4, 18) and the emergence of antibiotic resistance (5, 13,
27) highlight the need for increased molecular epidemiology
and surveillance of S. pneumoniae. Multilocus sequence typing
(MLST) characterizes bacterial isolates on the basis of the
sequences of designated housekeeping genes, and in the case
of S. pneumoniae, the sequences of seven housekeeping genes
are used (6, 7). Data can be easily uploaded onto a centralized
online database (http://spneumoniae.mlst.net/) for compara-
tive analysis. The S. pneumoniae database currently contains
over 5,000 sequence types.
MLST is a powerful tool for studying the genetic relatedness
of clinical isolates (10), investigating the origins of newly iden-
tified serotypes, such as serotype 6D (24), and tracking the
emergence and spread of multidrug-resistant isolates, such as
sequence type 320 (ST320) (23). MLST is typically performed
by isolating genomic DNA, amplifying the housekeeping genes
by PCR, and sequencing the resultant PCR amplicons. Anal-
ysis of sequence data is often a laborious process, as sequence
trace data must be manually reviewed, trimmed to the MLST
core region, and uploaded to the online database for allele and
ST identification. Advances in mass spectrometry (MS) tech-
nology have provided an alternative means to analyze nucleo-
tide composition, and MS is increasingly being employed for
the genetic characterization of pathogens such as hepatitis B
virus (8), Staphylococcus aureus (9), and Neisseria meningitidis
(11).
We have developed a new method for MLST of S. pneu-
moniae that utilizes matrix-assisted laser desorption ioniza-
tion–time of flight (MALDI-TOF) MS to identify alleles. Sim-
ilarly to traditional MLST, seven housekeeping genes are
amplified by PCR. Next, they are subject to in vitro transcrip-
tion and base-specific RNA cleavage. Analysis of cleavage frag-
ments by MALDI-TOF MS generates a mass signal pattern
that serves as a fingerprint of the sample isolate. Spectral data
are then compared to data in a reference library created by in
silico digestion of known allele types to identify the unknown
sample and any possible single-base deviations. The main ad-
vantage of the MALDI-TOF MS-based approach for MLST is
the speed of data acquisition and the automated analysis. Fol-
lowing the development and assessment of MALDI-TOF MS
for MLST of S. pneumoniae, this novel method was applied to
43 isolates carried by children in Papua New Guinea, a country
where pneumococcal carriage (15) and disease (2, 14) are
common but information on the population structure of bac-
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terial strains is lacking. This is the first study to report MLST
data for S. pneumoniae from Papua New Guinea.
MATERIALS AND METHODS
Bacterial isolates. Fifteen S. pneumoniae isolates of the following sequence
types (serotypes are in parentheses) previously typed by sequence-based MLST
were provided by the Pneumococcal Molecular Epidemiology Network (PMEN;
clones 11 to 26; http://www.sph.emory.edu/PMEN/pmen_table2.html): ST175
(19A), ST41 (19A), ST236 (19F), ST242 (23F), ST173 (23F), ST384 (6B), ST67
(serotype 14), ST289 (serotype 5), ST315 (6B), ST177 (19F), ST273 (6B), ST376
(6A), ST377 (35B), ST63 (15A), and ST388 (23F). We also examined four
serogroup 6 isolates, ST176 (6B), ST4240 (6C), ST639 (6D), and ST473 (6D),
from Fijian children that had previously been typed by sequence-based MLST
(24). Forty-three S. pneumoniae isolates were obtained from nasopharyngeal
swabs taken from Papua New Guinean children aged 6 to 24 months. Children
were recruited from the well baby immunization clinic conducted at Lopi Urban
Clinic in Goroka, Eastern Highlands Province, Papua New Guinea, during Feb-
ruary and March of 2009. Swabs were collected by study nurses and immediately
placed in 1 ml of skim milk glucose glycerol broth. Samples were transported to
the Papua New Guinea Institute of Medical Research, stored at 80°C, and sent
to Melbourne, Australia, where analysis was conducted. S. pneumoniae was
isolated from swabs, identified by standard methods (19), and serotyped by the
Quellung reaction, and pure isolates were stored in STGG medium (21) at
80°C until use.
PCR. Genomic DNA was extracted from fresh bacterial cultures using a
DNeasy Blood and Tissue kit (Qiagen, Doncaster, Australia). Primer pairs used
to amplify aroE, gdh, gki, recP, spi, xpt, and ddl (Table 1) were based on those
described by the Centers for Disease Control and Prevention (CDC; http://www
.cdc.gov/ncidod/biotech/strep/alt-MLST-primers.htm) or Enright and Spratt (7)
and listed on the MLST website (http://spneumoniae.mlst.net/). The primers
were tagged with a promoter sequence for T7 or SP6 RNA polymerase for
forward and reverse transcription, respectively (underlined in Table 1). PCRs
were performed using approximately 5 ng of genomic DNA, 0.125 U of Hot-
StarTaq DNA polymerase, 1 PCR buffer (Qiagen), 2.0 mM MgCl2, 0.2 M
forward and reverse primers (Sigma-Aldrich, Sydney, Australia), and 200 M
each deoxynucleoside triphosphate (Qiagen). PCR cycling conditions were a
15-min activation at 95°C, followed by 35 cycles of amplification at 94°C for 30 s,
62°C for 45 s, and 72°C for 60 s and a final extension at 72°C for 10 min. For
amplifications of spi, genomic DNA and primer concentrations were increased to
7.5 ng and 2.5 mM, respectively, and the annealing temperature was lowered to
56°C.
MLST by sequencing. Amplicons were sequenced in both directions using
capillary separation on an ABI 3730xl DNA analyzer with ABI BigDye Termi-
nator labeling (version 3.1; Australian Genome Research Facility) using primers
with only the T7 and SP6 tag sequences. Contiguous sequences were formed and
edited using the Sequencher program (version 4.9; Gene Codes Corporation,
Ann Arbor, MI). Core sequences were uploaded to the S. pneumoniae MLST
database for allele identification.
iSEQ library creation and simulation experiments. Reference sequence sets
were created by downloading allelic data from the S. pneumoniae MLST data-
base and modifying the sequences by adding forward and reverse primers and a
stretch of consensus sequence compiled from available GenBank entries (http:
//www.ncbi.nlm.nih.gov/GenBank/) to fill the gap between primer sequences and
the core MLST region. The iSEQ simulation tool (version 1.0) was used to assess
the discriminatory power of each tab-delimited text file-formatted reference
sequence set by in silico base cleavage and peak analysis (8). In short, the iSEQ
simulation tool software performs in silico base-specific cleavages at each C or T
of the forward or reverse strands covering all four bases and generating up to
four fragment mixtures of a single DNA strand. The mass of individual RNA
fragments in each mixture is calculated, and a mass spectrometric peak pattern
is simulated. Using an iterative clustering process, individual sequences (in a
reference sequence set) are analyzed, and discriminating features such as missing
peaks, additional peaks, and peak intensity changes are summarized in a dis-
criminatory power digit (11). On the basis of the sum of discriminatory features,
each reference sequence can be grouped into different discriminatory power
groups: very weak power (0 to 2 sum of features), weak power (2 to 4 sum of
features), medium power (4 to 8 sum of features), and strong power (8 sum of
features).
MLST by mass spectrometry. Following PCR amplification, samples were
prepared for MALDI-TOF MS analysis using MassCLEAVE T7/SP6 kit (Se-
quenom, Australia) reagents and the standard MassCLEAVE protocol (Seque-
nom, San Diego, CA) as previously described (11). Briefly, PCR amplicons
containing T7 and SP6 promoter sequences were digested with shrimp alkaline
phosphatase, transferred into 4 individual wells of a 384-well plate, and subjected
to four in vitro transcription and base-specific cleavage reactions. In vitro tran-
scription with T7 or SP6 RNA polymerase and dCMP or dTMP/dUMP replacing
the regular nucleoside enabled RNase A to cleave target sequences after U and
C residues, respectively (25). The resulting RNA fragments, corresponding to
T-forward, T-reverse, C-forward, and C-reverse cleavage patterns, were desalted
using an ion-exchange resin, and approximately 10 nl of each reaction mixture
was spotted on a 384-sample pad (Spectrochip; Sequenom). Fragments were
analyzed on a MALDI linear time of flight mass spectrometer (Sequenom) by
using the RT-Workstation (version 3.4) software package (Sequenom). Data
analysis was performed by using iSEQ software (version 1.0; Sequenom), which
compares experimental mass fingerprints acquired by MALDI-TOF MS to the in
silico mass fingerprints of the reference library sequences to identify the closest-
matching allele number and any single-nucleotide variations such as substitu-
tions, insertions, and deletions. Spectral data from the top two matches were
reviewed by the operator to confirm correct identification of the closest match.
Allele numbers were uploaded to the MLST online database for sequence type
identification.
TABLE 1. Primers for MALDI-TOF MS MLST of S. pneumoniae
Primer Sequence (5–3)a Source
aroE_T7F CAGTAATACGACTCACTATAGGGAGAAGGCTTCCTATTAAGCATTCTATTTCTCCCTTC CDC
aroE_SP6R CGATTTAGGTGACACTATAGAAGAGAGGCTACAGGAGAGGATTGGCCATCCATGCCC
ACACTG
CDC
gdh_T7F CAGTAATACGACTCACTATAGGGAGAAGGCTATGGACAAACCAGCNAGYTT mlst.net
gdh_SP6R CGATTTAGGTGACACTATAGAAGAGAGGCTGCTTGAGGTCCCATRCTNCC mlst.net
gki_T7F CAGTAATACGACTCACTATAGGGAGAAGGCTGGCATTGGAATGGGATCACC mlst.net
gki_SP6R CGATTTAGGTGACACTATAGAAGAGAGGCTTCTCCCGCAGCTGACAC mlst.net
recA_T7F CAGTAATACGACTCACTATAGGGAGAAGGCTGAATGTGTGATTCAATAATCACCTCA
AATAGAAGG
CDC
recA_SP6R CGATTTAGGTGACACTATAGAAGAGAGGCTTGCTGTTTCGATAGCAGCATGGATGGC
TTCC
CDC
spi_T7F CAGTAATACGACTCACTATAGGGAGAAGGCTCGCTTAGAAAGGTAAGTTATGAATTT CDC
spi_SP6R CGATTTAGGTGACACTATAGAAGAGAGGCTGTGATTGGCCAGAAGCGGAA mlst.net
xpt_T7F CAGTAATACGACTCACTATAGGGAGAAGGCTTTAACTTTTAGACTTTAGGAGGTCT
TATG
CDC
xpt_SP6R CGATTTAGGTGACACTATAGAAGAGAGGCTCGGCTGCTTGCGAGTGTTTTTCTTGAG CDC
ddl_T7F CAGTAATACGACTCACTATAGGGAGAAGGCTTAAAATCACGACTAAGCGTGTTCTGG CDC
ddl_SP6R CGATTTAGGTGACACTATAGAAGAGAGGCTAAGTAGTGGGTACATAGACCACTGGG CDC
a The underlined portion of the primer indicates the tagged T7 or SP6 promoter region.
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RESULTS
Simulation experiments. The S. pneumoniae MLST online
database contains an average of 295 alleles for each of the
seven housekeeping genes, aroE, gdh, gki, recP, spi, xpt, and ddl.
To determine whether MALDI-TOF analysis of the four cleav-
age reactions would allow accurate discrimination of allele
types, available allele sequences for each gene were down-
loaded from the MLST database and used for in silico simu-
lation experiments. Figure 1 shows the discriminatory power of
individual and combined cleavage reactions for 400 alleles of
the ddl gene. When all four cleavage reactions are used, 98.5%
of alleles were discriminated with strong power and 1.5% were
discriminated with medium power. Simulation experiments for
the remaining six MLST genes yielded similar results.
Assessment of MALDI-TOF MS MLST. To assess the suit-
ability of using a mass spectrometry platform for performing
MLST of S. pneumoniae, we screened 19 isolates previously
characterized by sequencing MLST, considered the “gold stan-
dard” method. Of the 15 PMEN isolates examined, MALDI-
TOF MS MLST gave the expected results for 101 of 105
alleles. The PCR amplicons of the four discrepant ddl alleles
were analyzed by traditional sequencing, and results confirmed
the allelic identification obtained by using MALDI-TOF MS,
suggesting that the ddl alleles for these four isolates had been
mislabeled and they had been correctly identified by MALDI-
TOF MS MLST. Distinguishing xpt-6 from xpt-147 required
manual interpretation of the spectral data, as the software
ranked xpt-147 as the top match but the spectral data matched
peak patterns expected for xpt-6, which was ranked as the
second-closest match. Sequencing verified the correct identifi-
cation to be xpt-6. Analysis of four serogroup 6 isolates previ-
ously typed by sequence-based MLST gave correct results for
three of the four isolates. For the fourth isolate (serotype 6C),
two pairs of alleles with extremely similar spectra, alleles
gdh-10 and gdh-25 and alleles ddl-369 and ddl-8, were incor-
rectly ranked by iSEQ software, which ranked the correct allele
as the second-best match instead of the best match. Overall,
MALDI-TOF MS MLST results matched sequence-based data
for 131 of 133 alleles (98.5% concordance). Since these 19
reference isolates represented a limited subset of serotypes
and STs, we proceeded to analyze field samples collected from
a population with high pneumococcal carriage rates.
MLST analysis of S. pneumoniae carriage isolates from
Papua New Guinea. Initially, 10 unknown carriage isolates
obtained from Papua New Guinean children were typed by
both traditional and MALDI-TOF MS MLST. For all 10, al-
lelic identification by the iSEQ software matched sequencing
results. Two new alleles identified by iSEQ were confirmed by
traditional sequence analysis: isolate 6563-03-067a had a sin-
gle-nucleotide variant of spi-187 and a single-nucleotide vari-
ant of gdh-3. In total, 29 isolates were typed by both MALDI-
TOF MS and sequencing MLST, and iSEQ results matched
sequencing data for 201/203 alleles, a 99.0% concordance rate.
Following this method of validation, the remaining unknown
isolates were typed solely by MALDI-TOF MS, and any new
alleles were confirmed by traditional sequencing.
We examined a total of 43 isolates obtained from 29 swabs
by serotyping and MALDI-TOF MS MLST (Table 2). Thirty-
nine of these isolates belonged to 23 serotypes, and 4 were
nontypeable. The majority of the Papua New Guinean iso-
lates were novel sequence types not previously listed in the
MLST database. Only serotypes 6C and 23F displayed clonal
attributes. Of the four 6C isolates, one was ST4240, previously
identified only in Australia and Fiji (24, 29), and the other
three were ST6747, the same as ST4240 except for gdh-8 re-
placing gdh-25. Three of the four 23F isolates were ST820,
found worldwide and associated with antibiotic resistance (3,
22, 28), and the fourth was ST6905, containing a single-nucle-
otide variation of spi-72. Other serotypes carried by multiple
children, such as serotype 14, were more genetically diverse. In
one instance, isolates with the same sequence type displayed
different serotypes (8 and 9L), evidence of capsular switching.
Strain 3108-03-002, a nontypeable isolate, had an identical
MLST profile as a serotype 6B isolate (3108-03-116a) obtained
from the same swab, suggesting that the nontypeable isolate
was a variant of the 6B isolate that produced little or no
capsule. For 14 alleles (indicated in Table 2), iSEQ software
identified a single-nucleotide change, which was later con-
firmed by sequencing. Overall, 30 novel sequence types and
seven new alleles were identified, and strain information and
allele sequences were submitted for entry into the MLST da-
tabase.
DISCUSSION
MLST by MALDI-TOF MS (MassARRAY iSEQ compar-
ative sequencing) analysis is a novel method for genetic typing
of S. pneumoniae that relies on the generation of sequence-
specific mass spectra for allele identification. In vitro transcrip-
tion of PCR products, followed by four base-specific cleavage
reactions, generates a distinct set of RNA fragments that can
be discerned from closely related alleles. We found a 99.0%
concordance rate between this new method and traditional
sequencing MLST. Similar to DNA sequencing machinery, a
mass spectrometer for MADLI-TOF MS would be best suited
for a core facility that serves multiple research groups, whereas
sample preparation does not require specialized laboratory
FIG. 1. Simulation results of 400 ddl alleles downloaded from the
online MLST database. The x axis displays the combination of cleavage
reactions (T forward [TF], T reverse [TR], C forward [CF], and C
reverse [CR]), and the y axis displays the percentage of alleles discrim-
inated with very weak, weak, medium, or strong power. For example,
if all four cleavage reactions are used, 98.5% of alleles are discrimi-
nated with strong power, whereas if the only the T-forward reaction is
used, 70.75% of alleles are discriminated with strong power.
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equipment. The running cost per isolate is similar for the two
methods (approximately US$125 for MALDI-TOF MS versus
US$130 for sequencing). Although the MALDI-TOF MS
method requires additional sample processing, the speed of
data analysis renders the MS-based platform more cost-effec-
tive than traditional MLST.
The iSEQ software automatically ranks the closest-matching
allele from the in silico database, but in cases of closely
matched sequence types, such as xpt-6 and xpt-147, the soft-
ware prompts the user to manually inspect the spectral data by
highlighting closely scoring reference sequences with an aster-
isk. In this study, manual inspection was recommended for
approximately 40% of total alleles. Spectral data are presented
in a user-friendly manner, with expected and actual peaks
labeled and linked to the corresponding cleavage fragments,
and spectra can be transformed into simulated banding pat-
terns for researchers more accustomed to viewing gels. Inter-
pretation of raw spectral data does not require expertise in
mass spectrometry and typically takes less than a minute to
perform.
Importantly, iSEQ was able to accurately identify single-
nucleotide variations within alleles. An electrospray ionization
MS method for MLST of S. pneumoniae that relies on primer
pairs internal to the core MLST loci (12) would not be suitable
for consistent detection of new alleles in a base- and sequence-
specific way. Potentially novel single-nucleotide variations
should be confirmed by sequencing, as sequencing reaction
chromatograms are required for the submission of a new allele
to the MLST online database. The iSEQ reference library
should be periodically updated to include new additions to the
MLST database.
Our study determined that the MALDI-TOF MS-based
TABLE 2. Serotypes and MLST types of S. pneumoniae isolates recovered from Papua New Guinean children
Sample Serotype
Allele no. MLST
sequence typearoE gdh gki recP spi xpt ddl
5133-12-001 6A 2 8 6 16 15 6 5 6746a
2254-05-001 6A 2 8 4 131 6 1 11 4274
3108-03-116a 6B 8 5 244 1 6 277 59 6942a
5877-11-006 6C 93 25 4 15 17 20 8 4240
7704-10-001 6C 93 8 4 15 17 20 8 6747a
7856-08-001 6C 93 8 4 15 17 20 8 6747a
8448-08-081 6C 93 8 4 15 17 20 8 6747a
1522-14-011 8 15 15 8 16 6 20 17 6748a
5877-11-001 8 12 10 6 16 6 6 11 6749a
5158-02-004 9L 12 10 6 16 6 6 11 6749a
8308-08-001 10A 7 25 29 4 48 20 28 6750a
6563-03-067a 13 7 320a 9 16 285a 1 18 6903a
2099-05-001 14 1 164 4 5 6 1 18 6925a
3811-06-001 14 1 2 133 5 6 1 28 6751a
3274-01-027 14 1 2 4 5 6 1 176 6752a
5033-02-001 15A 7 13 4 16 15 1 17 3058
9916-13-004 15B 7 119 312a 4 6 103 14 6926a
8448-08-007 15C 7 119 312a 4 6 103 11 6927a
1522-14-002 16F 8 8 312a 8 6 103 245 6928a
1621-08-002 16F 1 226 4 5 9 224 216 6753a
4197-09-001 18F 5 31 8 1 9 11 31 291
3274-01-001 19A 1 10 9 16 6 1 11 6913a
7576-16-001 19A 215a 12 19 8 6 38 120 6929a
6563-03-016 19A 215a 12 19 8 6 38 120 6929a
3274-01-002a 19A 215a 12 19 8 6 38 469a 6920a
8203-01-008 19F 7 8 312a 131 5 7 11 6904a
907-10-001 19F 7 119 19 16 14 14 28 6930a
546-11-001 21 7 2 4 15 6 1 18 6754a
3477-06-003 23A 13 9 9 16 6 20 11 6755a
3477-06-001 23A 1 2 4 5 6 1 31 6756a
1489-07-001 23F 10 13 53 1 72 38 31 802
872-11-001 23F 10 13 53 1 286a 38 31 6905a
6563-03-001 23F 10 13 53 1 72 38 31 802
2371-03-001 23F 10 13 53 1 72 38 31 802
658-13-001 33 7 60 19 1 6 14 70 6757a
4990-01-002 34 45 13 6 12 9 14 11 6758a
872-11-007 35B 216a 10 312a 131 6 7 11 6921a
3477-06-038 35F 1 5 1 50 6 1 18 6931a
1621-08-001 45 8 119 312a 66 14 103 28 6932a
3108-03-002 NTb 8 5 244 1 6 277 59 6924a
6084-12-001 NT 7 25 4 4 48 20 28 6759a
5033-02-015 NT 93 25 4 15 17 20 8 4240
7704-10-004 NT 1 13 4 5 9 17 7 6760a
a Newly identified by this study.
b NT, nontypeable.
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method for MLST of S. pneumoniae was both rapid and accu-
rate. The finding that the majority of Papua New Guinean
isolates displayed novel sequence types suggests that strains
from this geographic region, and presumably other developing
countries, are underrepresented in the MLST database. The
MLST data presented here provide a population snapshot of
the S. pneumoniae sequence types carried by children in Papua
New Guinea prior to widespread pneumococcal vaccination,
important information for planning vaccination strategies and
monitoring serotype replacement following pneumococcal vac-
cination, as well as identifying the emergence and spread of
antibiotic-resistant clones.
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